Zyclara Disease Interactions
There are 2 disease interactions with Zyclara (imiquimod topical).
Imiquimod topical (applies to Zyclara) eczema
Moderate Potential Hazard, High plausibility.
Imiquimod may exacerbate inflammatory conditions of the skin. Local reactions are commonly associated with the use of imiquimod and may extend beyond the application site onto the surrounding skin. These reactions include erythema, edema, vesicles, erosion/ulceration, weeping/exudate, flaking/scaling/dryness, and scabbing/crusting. Therapy with topical imiquimod should be avoided or used with caution in patients with eczematous conditions.
References
- (2001) "Product Information. Aldara (imiquimod topical)." 3M Pharmaceuticals
Imiquimod topical (applies to Zyclara) sunburn
Moderate Potential Hazard, High plausibility.
The use of imiquimod may be associated with heightened sunburn susceptibility. Patients with sunburn should be cautioned not to use imiquimod until fully recovered. Exposure to sunlight, including sunlamps, should be avoided or minimized during treatment, and protective clothing (e.g., hat) is recommended when exposure is unavoidable.
References
- (2001) "Product Information. Aldara (imiquimod topical)." 3M Pharmaceuticals
Zyclara drug interactions
There are 6 drug interactions with Zyclara (imiquimod topical).
More about Zyclara (imiquimod topical)
- Zyclara consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (49)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: topical anti-infectives
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.